CLEVELAND CLINIC LERNER COM-CWRU
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma is a funding opportunity from CLEVELAND CLINIC LERNER COM-CWRU, up to 402500, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
Project Summary Glioblastoma (GBM) is the most lethal primary brain tumor with poor prognosis. GBM contains heterogeneous cancer cells including glioma stem cells (GSCs) and harbors abundant tumor-associated macrophages (TAMs). Because the majority of TAMs are tumor-promoting macrophages (pTAMs, M2) that support…